Browse grants
Federal opportunities with plain-English eligibility summaries. We aggregate public records — always verify the details on the funder’s site before applying.
OVC FY 2026 Services for Victims of Technology-Facilitated Abuse
Due in 2 daysOffice for Victims of Crime · $0–$1M
This is a notice of funding opportunity (NOFO) for the OVC FY 2026 Services for Victims of Technology-Facilitated Abuse. This opportunity supports victim services to address technology-facilitated abuse (TFA). TFA includes, but is not limited to, crimes commonly referred to as image-based sexual abuse, non-consensual distribution of intimate images, sextortion, synthetic intimate images (“deepfakes”), online stalking, harassment, and abuse.
OVC FY 2026 Technology to Support Services for Victims of Crime
Due in 2 daysOffice for Victims of Crime · $0–$1.1M
This is a notice of funding opportunity (NOFO) for the OVC FY 2026 Technology to Support Services for Victims of Crime. This opportunity supports projects that create, expand, or enhance the use of technology by victim service organizations to improve interaction with crime victims, elevate service quality, and ensure accessibility and responsiveness. This funding is not intended to support projects that— • primarily fund equipment or supply purchases without substantial technological development components. • procure existing, commercial, off-the-shelf technology solutions. • duplicate existing services or products. • include active investigation or prosecution activities. Note: Applicants may propose projects related to hotlines if the focus of the proposal is on developing an innovative technological infrastructure or expansion and not solely on operations.
OVC FY 2026 Services for Victims of Crime
Due in 2 daysOffice for Victims of Crime · $0–$500K
This is a notice of funding opportunity (NOFO) for the OVC FY 2026 Services for Victims of Crime. This opportunity supports the development, expansion, and strengthening of victim service programs for all victims of crime throughout the United States and its territories. OVC invites proposals for projects to provide direct services to all victims of crime, including child and youth victims; victims of elder abuse, fraud, and exploitation; and other types of crime victims. Victim services may include, but are not limited to, emergency assistance, case management, shelter and housing, medical and dental care, victim advocacy, transportation, childcare, legal services, and employment assistance. All services proposed under this program must directly address the needs of crime victims. OVC has dedicated funding streams and grant opportunities for services for victims of human trafficking. As such, human trafficking projects are not eligible for this funding opportunity.
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
Due in 3 daysNational Institutes of Health · Amount varies
This Notice of Funding Opportunity (NOFO) solicits applications to develop web-accessible data archives to capture, store, and curate data related to BRAIN Initiative activities. The data archives will work with the research community to incorporate tools that allow users to analyze and visualize the data, but the creation of such tools is not part of this NOFO. The data archives will use appropriate standards to describe the data, but the creation of such standards is not part of this NOFO. A goal of this program is to advance research by creating a community resource data archive with appropriate standards and summary information that is broadly available and accessible to the research community for furthering research.
BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed)
Due in 10 daysNational Institutes of Health · Amount varies
This BRAIN Initiative Notice of Funding Opportunity (NOFO) is to support scaled reagent production and distribution facilities involving technologies to access brain cell types. Facilities for production and distribution of these reagents by a broad set of neuroscientists will be encouraged. This NOFO is part of the BRAIN Initiative Armamentarium for Brain Cell Access transformative project. Efforts will be supported to produce and distribute gene transfer, gene regulation, and genome engineering reagents for use in both genetically tractable and less tractable systems, including primates and human tissue, which are relevant for future translational efforts. Reagents to be produced and distributed are those designed and validated under other NOFOs from the Armamentarium transformative project.
INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
Due in 10 daysNational Institutes of Health · Amount varies
The purpose of the INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Predoctoral to postdoctoral Fellow Transition award (F99/K00) is to recruit exceptional graduate students from a variety of research fields to pursue postdoctoral training focused on Down syndrome related research. Talented graduate students from disciplines including, but not limited to, genetics, biochemistry, data science, imaging, engineering and neurobiology are invited to apply to this opportunity. Prospective applicants are strongly encouraged to contact the INCLUDE Program Staff prior to initiating plans for application submission.
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Due in 15 daysNational Institutes of Health · Amount varies
The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating women, neonates, and children. The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating women, fetuses, neonates, and children, including those with disabilities.
Home Study and Post-Release Services for Unaccompanied Alien Children​​
Due in 15 daysAdministration for Children and Families - ORR · $1M–$50M
The Office of Refugee Resettlement (ORR) provides temporary housing and care for children who arrive in the United States alone. These are children who are under 18 years old, don't have legal permission to be in the U.S., and don't have a parent or legal guardian in the U.S. who can take care of them. ORR runs the Home Study and Post-Release Services Program to help these children. Before placing a child with a sponsor, ORR carefully checks potential homes to make sure they're safe and appropriate. After placement, ORR provides ongoing support to help children and their sponsors succeed. This support helps children adjust to living with their sponsor, connect with their community, stay safe and healthy, and navigate the immigration court process. The goal is to make sure children are placed in safe homes and have the support they need to thrive while their immigration cases move forward.
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Due in 16 daysNational Institutes of Health · Amount varies
The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating women, neonates, and children. The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating women, fetuses, neonates, and children, including those with disabilities.
OVC FY 2026 Victims of Crime Act (VOCA) Victim Compensation Formula Grant
Due in 17 daysOffice for Victims of Crime · $0
This is a notice of funding opportunity (NOFO) for the OVC FY 2026 Victims of Crime Act (VOCA) Victim Compensation Formula Grant. Eligible victim compensation programs can use these funds to provide crime victims with compensation, support, and services to aid their restoration after criminal violence, including costs associated with medical fees, lost income, dependent care, funeral expenses, and relocation expenses.
OVC FY 2026 Victim of Crime Act (VOCA) Victim Assistance Formula Grant
Due in 17 daysOffice for Victims of Crime · $0
This is a notice of funding opportunity (NOFO) for the OVC FY 2026 Victims of Crime Act (VOCA) Victim Assistance Formula Grant. This opportunity provides an annual VOCA victim assistance grant to all states and most territories to provide subgrants to local organizations and public agencies that provide services directly to crime victims. Examples of services provided include crisis counseling, telephone and onsite information and referrals, criminal justice support and advocacy, shelter, therapy, and additional assistance.
Predictive Analytics in Child Welfare Demonstration Grants
Due in 22 daysAdministration for Children and Families - ACYF/CB · $400K–$600K
This NOFO has been modified to update language in the optional documents for bonus points, and bonus point criteria sections.As child welfare agencies increasingly use data to inform practice, targeted implementation, analytic support, and information sharing are needed to ensure the responsible use of predictive analytics. This funding opportunity supports child welfare jurisdictions in serving as demonstration sites for the effective use and future replication of predictive analytics at the national level.Grantees will focus on meeting the following objectives: Designing, implementing, and testing predictive analytics strategies, Building and sustaining agency capacity, Participating in collaboration and shared learning, Evaluating training and technical assistance activities.
OVC FY 2026 Invited to Apply - Byrne Discretionary Community Project Grants/Byrne Discretionary Grants Program
Due in 24 daysOffice for Victims of Crime · $0–$3.5M
With this Notice of Funding Opportunity, OVC seeks to support projects designated for funding in the Department of Justice Appropriations Act, 2026 (Pub. L. No. 119-74, Div. A, Title II.) to improve the functioning of the criminal justice system, to prevent or combat juvenile delinquency, and to assist victims of crime (other than compensation).
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
Due in 25 daysNational Institutes of Health · Up to $100K
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to identify new druggable targets for pain within the understudied druggable proteome. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s) listed in this NOFO. This NOFO is intended to jumpstart research on understudied proteins within the context of pain and pain management and provide applicants with sufficient funding to perform basic biochemical and/or biological work to further the characterization of understudied proteins to identify new druggable targets for pain. This NOFO is part of the NIH Helping to End Addiction Long Term (HEAL) initiative to accelerate the development of novel medications to treat all aspects of the opioid addiction cycle, including progression to chronic use, withdrawal symptoms, craving, relapse, and overdose.
OVC FY 2026 Increasing Services for American Indian and Alaska Native Victims of Human Trafficking in Urban Centers Program
Due Jul 23, 2026Office for Victims of Crime · $0–$450K
This program is intended to Increase the availability of victim services for AI/AN victims of human trafficking in urban centers and improve the organizational capacity of funded organizations to provide victim services.
OVC FY 2026 Tribal Victim Services Set-Aside Formula Program
Due Aug 6, 2026Office for Victims of Crime · $0
This opportunity supports the provision of services to crime victims in American Indian/Alaska Native communities through a discretionary administrative formula program funded under a set-aside designated by law from the Crime Victims Fund. The program is not competitive and is open only to federally recognized Indian Tribes, Alaska Native Claims Settlement Act Regional Corporations, and their authorized designees. Funding may be used to support a Tribe's victim services and is available for a range of expenses. Tribes can also use Tribal Victim Services Set-Aside grants for construction or for refurbishing, renovating, or improving structures for victim services office space, shelter for victims, and related purposes.
Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)
Due Aug 7, 2026National Institutes of Health · Amount varies
The purpose of theNative American Research Centers for Health (NARCH) program is to fund federally-recognized American Indian/Alaska Native (AI/AN) tribes and tribal organizations to support health-related research, research career enhancement, and research infrastructure enhancement activities.
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
Due Sep 28, 2026National Institutes of Health · Amount varies
The purpose of this announcement is to encourage investigators to pursue a small clinical trial to obtain critical information necessary to advance recording and/or stimulating devices to treat central nervous system disorders and better understand the human brain (e.g., Early Feasibility Study). Clinical studies supported may consist of acute or short-term procedures that are deemed Non-Significant Risk (NSR) by an Institutional Review Board (IRB), or Significant Risk (SR) studies that require an Investigational Device Exemption (IDE) from the FDA, such as chronic implants. The clinical trial should provide data to answer key questions about the function or final design of a device. This final device design may require most, if not all, of the non-clinical testing on the path to more advanced clinical trials and market approval. The clinical trial is expected to provide information that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. Activities supported by this Funding Opportunity include a small clinical trial to answer key questions about the function or final design of a device.As part of the BRAIN Initiative, NIH has initiated a Public-Private Partnership Program (BRAIN PPP) that includes agreements (Memoranda of Understanding, MOU) with a number of device manufacturers willing to make such devices available, including devices and capabilities not yet market approved but appropriate for clinical research. In general it is expected that the devices' existing safety and utility data will be sufficient to enable new IRB NSR or FDA IDE approval without need for significant additional non-clinical data. For more information on the BRAIN PPP, see http://braininitiative.nih.gov/BRAIN_PPP/index.htm
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
Due Sep 28, 2026National Institutes of Health · Amount varies
The purpose of this announcement is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study, as well as a subsequent small clinical study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This FOA is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
Due Nov 16, 2026National Institutes of Health · Up to $50K
The purpose of this Notice of Funding Opportunity (NOFO) is to invite Small Research Grant (R21) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Direct involvement of key stakeholders where appropriate is encouraged. These applications should be for small research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data and the secondary analysis of existing data.